Rodrigo Duterte
President of the Philippines, 2016-2022
- Partial2
- Facts1
- Drivers1
- Indicators2
- Related people0
President of the Philippines, 2016-2022
Factrail analysis: signed the Universal Health Care Act (RA 11223) into law, a structural expansion of health coverage the model reads as a positive welfare contribution on this specific measure. This assessment is scoped strictly to the documented legislation and is not a comprehensive judgment of his tenure.
Rodrigo Duterte’s slice of Factrail’s verified causal web — the facts, drivers and welfare indicators their actions connect to. Select any node to trace a path.
Loading network…
Projected scenarios from the Factrail model. These describe what may happen under stated assumptions — they are not confirmed facts and may change as new data arrives.
Horizon: Jun 9, 2026 – Dec 31, 2027
Under a baseline in which global immunization investment only partially recovers and vaccine hesitancy stays elevated, MCV1 coverage holds near its 83-84% plateau and the global under-five mortality rate continues to fall but more slowly, remaining above the SDG 3.2 normal line of 25 per 1,000 through 2027.
Assumptions
Assumes no major new donor surge or pandemic-scale disruption; immunization-investment intensity stays near its partially recovered ~0.75 level; vaccine hesitancy remains elevated relative to pre-2017; ~14.5 million zero-dose children are only gradually reduced. A baseline, not a worst case.
This is a projected scenario, not a confirmed fact.
Updated
| Promise | Status | Deadline |
|---|---|---|
Deliver universal health coverage for all Filipinos under RA 11223 | Partially fulfilled | — |
Deliver universal health coverage for all Filipinos under RA 11223“Paraphrase: every Filipino will be automatically enrolled and guaranteed access to quality health services with financial protection under the Universal Health Care Act.” | Partially fulfilled | Dec 31, 2027 |
A chronology will appear once enough dated facts are linked.
No affiliated people are linked yet.
Within the Factrail dataset, Rodrigo Duterte is tracked through a single documented action with a single recorded edge: signing the Universal Health Care Act (RA 11223) into law on 20 February 2019. Everything in his entry here flows from that one fact, and the entry is deliberately scoped to it. This is not an account of his presidency, his politics or his broader record; it is a narrow reading of one head-of-state act and the welfare chain the model attaches to it. Holding that scope is the most important thing to understand about the figure that follows.
The fact is classified as a policy and verified at high confidence as having occurred. The model reads the signing as the decisive head-of-state step that enacted a structural expansion of health coverage in the Philippines, and treats it as a positive welfare contribution on that specific measure. The reasoning the dataset encodes is institutional rather than personal: a president signing a universal-coverage statute is the act that converts a legislative proposal into law, and it is that conversion the model is crediting, not any claim about motive or about the rest of the tenure.
Because there is exactly one edge in the documented record, the aggregate score the dataset produces for Duterte sits near zero. That near-zero figure should be read as a statement about coverage, not about character. It reflects how little of his record is captured in this dataset, and it is explicitly not a comprehensive verdict. A single documented act, however consequential the legislation, cannot sum to a full assessment, and the model does not pretend otherwise.
The graph routes the signing through one driver: public and donor investment in immunization systems, a fiscal-institutional factor carrying a current weight of 0.7. The logic is that universal coverage and automatic PhilHealth enrolment could expand the financing and access that underpin primary care and routine vaccination. From that driver the chain extends forward to two verified welfare indicators.
The first is first-dose measles vaccination coverage globally (MCV1), a higher-is-better measure weighted at 0.85 and described as a leading indicator of routine-immunization system strength. In net terms this indicator carries the strongest positive impact value in the record, consistent with the idea that sustained immunization financing tends to lift coverage. The second is the under-five mortality rate, a headline child-survival indicator weighted at 0.95 and read as lower-is-better. Its net impact value is negative in the dataset, which here means movement in the favourable direction: a lower under-five mortality rate is the welfare gain, and the negative net figure encodes that improvement rather than any harm.
Read together, these two indicators describe the intended mechanism in full: more immunization financing, higher vaccine coverage, fewer preventable child deaths. The most important positive entry in the record is the contribution to measles coverage; the most important favourable-direction entry on the mortality side is the recorded reduction in under-five deaths. Both run the same way, toward better child-health outcomes, even though one is expressed as a rise in a good number and the other as a fall in a bad one.
Several caveats are built into the entry, and they matter as much as the figures. The model flags the fact-to-driver link at only medium confidence, because the law's real-world effect depends heavily on implementation, on financing continuity and on a rollout that plays out over a multi-year horizon. A statute that creates entitlements on paper does not automatically deliver clinics, vaccines and enrolment in practice, and the dataset does not assume that it does.
The underlying promise attached to the act is recorded as only partially fulfilled and still in need of review. That status is the honest centre of the entry: it treats the signing as a genuine structural enabler whose downstream welfare payoff remains contingent and, for now, unproven. The positive direction the model records is a claim about the kind of effect universal coverage and immunization investment tend to produce, framed as analysis of a plausible pathway, not as a measured outcome already banked.
The final and most important caveat is one of scope. This is one edge in a documented record, assessed strictly on its own terms. Factrail does not extend this narrow finding into any broader judgment of Duterte's presidency, and neither should a reader. The dataset says something specific and limited — that a head-of-state signature enacted a structural health-coverage expansion whose welfare benefits are credible but not yet demonstrated — and it stops precisely there.